Dark History of Clinical Trials Part 5
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
Dark History of Clinical Trials Part 5
-
Narrated by:
-
By:
About this listen
In this powerful installment of Dark History of Clinical Trials, we examine one of the most tragic and transformative episodes in pharmaceutical history: the thalidomide disaster.
Marketed as a safe sedative and morning sickness treatment in the late 1950s, thalidomide was distributed to thousands—only to cause severe congenital deformities and pregnancy losses across the globe. This catastrophe exposed critical flaws in drug testing, marketing, and approval processes.
In this episode, we uncover:
- The rise and reckless distribution of thalidomide
- The real human cost behind corporate and regulatory failures
- How this tragedy reshaped modern drug approval laws
- The birth of the FDA’s MedWatch program and tighter safety controls
- Why we now distinguish between OTC and controlled medications
Understanding this dark chapter is key to appreciating the safeguards we often take for granted today.
What listeners say about Dark History of Clinical Trials Part 5
Average Customer RatingsReviews - Please select the tabs below to change the source of reviews.
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.